Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 410 | 11 | 359 | 525 | 468 |
| Gross Profit | 410 | 11 | 359 | 525 | 468 |
| Operating Expenses | 17,723 | 15,166 | 15,185 | 14,925 | 12,393 |
| Operating Income | -17,313 | -15,155 | -14,826 | -14,400 | -11,925 |
| Other Income | 1,072 | 933 | 60 | 34 | 14 |
| Pre-tax Income | -16,241 | -14,222 | -14,766 | -14,366 | -11,911 |
| Income Tax | 14 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -16,255 | -14,235 | -14,766 | -14,366 | -11,911 |
| Net Income | $-16,255 | $-14,235 | $-14,766 | $-14,366 | $-11,911 |
| EPS Basic Total Ops | -22.00 | -4.50 | -20.00 | -21.00 | -46.00 |
| EPS Basic Continuous Ops | -22.07 | -4.42 | -20.05 | -21.16 | -45.78 |
| EPS Diluted Total Ops | -22.00 | -4.50 | -20.00 | -21.00 | -46.00 |
| EPS Diluted Continuous Ops | -22.07 | -4.42 | -20.05 | -21.16 | -45.78 |
| EBITDA(a) | $-17,755 | $-15,425 | $-14,547 | $-14,114 | $-11,645 |